Expertise in
13
conditions

Nobumasa Mizuno

Nagoya, JP 
Expertise in
13
conditions
Nagoya, JP 

Overview

Nobumasa Mizuno practices practicing medicine in Nagoya, Japan.

Mizuno is highly rated in 13 conditions, according to our data. Their clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Islet Cell Tumor, Endoscopy, and Gastrostomy.

They are actively involved in clinical research, co-authoring 198 peer reviewed articles and participating in 1 clinical trial.

Locations

Nagoya, Japan
Other Locations
Hiroshima, Japan
Okazaki, Japan
Sawara, 8140001, Japan
Tokyo, Japan
Yayoi, 1138657, Japan
Gifu-shi, 5011194, Japan
Minami, Japan
Shizuoka, 4118777, Japan
Sakawa, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations
A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations
Enrollment Status: Active_not_recruiting
Publish Date: August 21, 2026
Intervention Type: Drug
Study Drugs: Tucatinib, Trastuzumab, Fulvestrant
Study Phase: Phase 2

198 Total Publications

NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: results from an open-label, phase II study.
NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: results from an open-label, phase II study.
Journal: ESMO gastrointestinal oncology
Published: August 12, 2026

Frequently Asked Questions about Nobumasa Mizuno

Is Nobumasa Mizuno a top-rated expert for Pancreatic Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Nobumasa Mizuno is classified as an Elite expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nobumasa Mizuno participate in research or clinical trials?

Yes. Nobumasa Mizuno has published 198 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Nobumasa Mizuno's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mizuno's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile